cas 908269-35-2|| where to buy 7-(1H-1,2,3-Triazol-5-yl)imidazo[1,2-a]pyridine

Produktname:7-(1H-1,2,3-Triazol-5-yl)imidazo[1,2-a]pyridine

IUPAC Name:5-{imidazo[1,2-a]pyridin-7-yl}-1H-1,2,3-triazole

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge
CM268965-1g	1-2 Weeks	ƏƏţǟ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 908269-35-2 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:908269-35-2; Molekulare Formel:C9H7N5; Schmelzpunkt:-; SMILES-Code:C12=NC=CN1C=CC(C3=CN=NN3)=C2; Dichte:

: Katalognummer:CM268965; Molekulargewicht:185.19; Siedepunkt:; Mdl-Nr.:MFCD13177250; Lagerung:

: Imidazopyridines; With four imidazopyridine-containing drugs and one pyrazolopyridine-containing drug on the market, bicyclic pyridines containing ring-junction nitrogen are privileged structures in medicinal chemistry. With two nitrogen atoms with potential to serve as hydrogen bond acceptors, imidazopyridines and pyrazolopyridines may boost binding to target proteins and elevate potency. In addition, these structures have found utility in FBDD, covalent inhibitors, reducing metabolic liabilities, and creating novel chemical space and intellectual properties. With many of the advanced intermediates now commercially available, they will find more and more applications in drug discovery.; imidazole pyridine supplier; As a imidazole pyridine supplier,we will offer our best price with good quality for you.

: Triazoles; Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.